Related Experiment Video
Updated: May 9, 2025
12:27
Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
Published on: August 22, 2016
7.5K
Poly-ε-caprolactone/chitosan/whitlockite electrospun bionic membrane conjugated with an E7 peptide for bone
Guangzi Chen1, Tao Xu1, Ran Gao2
1Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, P.R. China.
Stem Cell Research & Therapy
|April 28, 2025
Summary
A novel biomimetic periosteum membrane effectively repairs bone defects by promoting new bone and blood vessel formation. This tissue engineering approach offers a promising solution for critical bone injuries.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- The natural periosteum is crucial for bone repair but limited in clinical availability.
- Developing a biomimetic periosteum is essential for addressing bone defect repair challenges.
Purpose of the Study:
- To engineer a poly-ε-caprolactone/chitosan/Whitlockite/E7 peptide (PCL/CS/WH/E7) bionic membrane for bone defect repair.
- To evaluate the biocompatibility, osteogenic, and angiogenic potential of the developed bionic membrane.
Main Methods:
- Fabrication of PCL/CS/WH/E7 bionic membrane using electrospinning.
- In vitro assessment of cell viability, proliferation, mineralization, and gene expression of bone marrow mesenchymal stem cells (BMSCs) and endothelial progenitor cells (EPCs).
- In vivo evaluation of bone regeneration and angiogenesis using Micro-CT and histological analysis.
Main Results:
- The PCL/CS/WH/E7 membrane demonstrated enhanced hydrophilicity and cytocompatibility.
- Synergistic effects of chitosan, E7 peptide, and Whitlockite promoted angiogenesis and osteogenic differentiation.
- Significant bone defect bridging, new bone formation, and vascularization were observed within three weeks post-implantation.
Conclusions:
- The PCL/CS/WH/E7 bionic membrane facilitates efficient bone tissue repair.
- This engineered membrane provides a viable clinical strategy for treating critical bone defects.
